No Reduction in HRQOL With Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Neoadjuvant chemoradiotherapy did not lower postoperative health-related quality of life compared with surgery alone for patients with esophageal or junctional cancer.
Source: OncLive